Y
338840
vs
K
KOSPI 200
Over the past 12 months, Y Biologics Inc has significantly outperformed KOSPI 200, delivering a return of +303% compared to the KOSPI 200's +108% growth.
Stocks Performance
338840 vs KOSPI 200
Performance Gap
338840 vs KOSPI 200
Performance By Year
338840 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Y Biologics Inc
Glance View
Y-Biologics, Inc. operates as a biopharmaceutical company. The company is headquartered in Daejeon, Daejeon and currently employs 54 full-time employees. The company went IPO on 2023-12-05. The firm is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as well as others.